Teachers Retirement System of The State of Kentucky Acquires New Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Teachers Retirement System of The State of Kentucky acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 53,061 shares of the biotechnology company’s stock, valued at approximately $6,142,000.

Several other hedge funds have also recently bought and sold shares of the company. Arizona State Retirement System lifted its position in Axon Enterprise by 0.4% in the 3rd quarter. Arizona State Retirement System now owns 18,332 shares of the biotechnology company’s stock valued at $2,122,000 after purchasing an additional 71 shares during the last quarter. Kovack Advisors Inc. lifted its position in Axon Enterprise by 2.1% in the 3rd quarter. Kovack Advisors Inc. now owns 3,875 shares of the biotechnology company’s stock valued at $449,000 after purchasing an additional 80 shares during the last quarter. IFP Advisors Inc raised its position in shares of Axon Enterprise by 36.8% during the 3rd quarter. IFP Advisors Inc now owns 364 shares of the biotechnology company’s stock worth $28,000 after buying an additional 98 shares in the last quarter. Utah Retirement Systems raised its position in shares of Axon Enterprise by 0.8% during the 3rd quarter. Utah Retirement Systems now owns 12,100 shares of the biotechnology company’s stock worth $1,401,000 after buying an additional 100 shares in the last quarter. Finally, Atria Wealth Solutions Inc. raised its position in shares of Axon Enterprise by 5.7% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 2,168 shares of the biotechnology company’s stock worth $202,000 after buying an additional 116 shares in the last quarter. 75.62% of the stock is currently owned by institutional investors.

Insider Transactions at Axon Enterprise

In other news, Director Mark W. Kroll sold 3,549 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, March 7th. The shares were sold at an average price of $220.73, for a total value of $783,370.77. Following the transaction, the director now directly owns 10,142 shares of the company’s stock, valued at $2,238,643.66. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Director Mark W. Kroll sold 3,549 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, March 7th. The shares were sold at an average price of $220.73, for a total value of $783,370.77. Following the transaction, the director now directly owns 10,142 shares of the company’s stock, valued at $2,238,643.66. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 591 shares of Axon Enterprise stock in a transaction that occurred on Friday, March 3rd. The stock was sold at an average price of $212.52, for a total transaction of $125,599.32. Following the completion of the transaction, the director now directly owns 8,179 shares in the company, valued at $1,738,201.08. The disclosure for this sale can be found here. Insiders have sold a total of 346,891 shares of company stock valued at $65,526,959 over the last ninety days. Corporate insiders own 6.90% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. JMP Securities boosted their price target on shares of Axon Enterprise from $195.00 to $235.00 and gave the stock a “market outperform” rating in a research report on Wednesday, February 1st. Needham & Company LLC restated a “buy” rating and set a $240.00 price target on shares of Axon Enterprise in a research report on Wednesday, March 1st. Raymond James downgraded shares of Axon Enterprise from a “strong-buy” rating to an “outperform” rating and set a $223.00 price target on the stock. in a research report on Friday, February 17th. JPMorgan Chase & Co. downgraded shares of Axon Enterprise from an “overweight” rating to a “neutral” rating and set a $224.00 price target on the stock. in a research report on Thursday, March 2nd. Finally, Morgan Stanley boosted their price target on shares of Axon Enterprise from $130.00 to $155.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 13th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $221.64.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $213.12 on Friday. The firm’s 50 day simple moving average is $196.30 and its 200-day simple moving average is $166.30. The company has a market cap of $15.53 billion, a P/E ratio of 106.36 and a beta of 0.92. The company has a debt-to-equity ratio of 0.53, a current ratio of 3.00 and a quick ratio of 2.66. Axon Enterprise, Inc. has a fifty-two week low of $82.49 and a fifty-two week high of $226.00.

Axon Enterprise Profile

(Get Rating)

Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.